NEW YORK (GenomeWeb) – The US Department of Justice said on Thursday that Biotheranostics has agreed to pay $2 million to settle allegations that the company improperly billed Medicare for molecular breast cancer tests.
...and receive Daily News bulletins.
Already have an account?Login Now.
23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.
A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.
In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.
Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.
This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.
This webinar will discuss ongoing work to apply T-cell receptor sequencing (TCRseq) approaches to immunotherapy monitoring for melanoma patients.
This webinar will provide an overview of how St. Jude Cloud, a public repository of pediatric cancer genomics data and analysis tools, is impacting cancer research.
In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.